Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Leflunomide tablet and preparation technology thereof

A leflunomide tablet and its preparation technology are applied in pill delivery, bone diseases, non-central analgesics, etc., and can solve problems such as unsatisfactory curative effect

Inactive Publication Date: 2014-08-20
王俊国
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Existing drugs for the treatment of rheumatoid arthritis and painful osteoarthritis (arthrosis, degenerative joint disease) have unsatisfactory aspects such as curative effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Leflunomide tablet and preparation technology thereof
  • Leflunomide tablet and preparation technology thereof
  • Leflunomide tablet and preparation technology thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017] The present invention is further explained below in conjunction with the examples, but the examples do not limit the present invention in any form.

[0018] (1) Making tablet cores: pass leflunomide, lactose, pregelatinized starch, hydroxypropylmethyl cellulose, and sodium starch glycolate through a 100-mesh sieve, and add them to the wet mixing granulator according to the method of equal increments. Evenly, mixed powder is obtained; dissolve polysorbate-80 and magnesium stearate in 30 to 50 times of ethanol, add to the above mixed powder, mix, and then add 12% pregelatinized starch for pulping to the mixed Powder, made into 18-40 mesh granules, dried at 60-70°C, sieved with 24-mesh sieve, collected when the moisture content was 1.0-3.0%, and prepared tablet cores for later use;

[0019] (2) Coating: the stomach-soluble film coating premix is ​​formulated with 80% ethanol into a 11% suspension, stirred and mixed for 60 minutes for later use; 2~3 rpm, adjust the distanc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a leflunomide tablet and a preparation technology and use thereof. The product is prepared from leflunomide, milk sugar, pregelatinized starch, hydroxypropyl methyl cellulose, carboxymethyl starch sodium, polysorbate-80, 12% slushing pregelatinized starch, magnesium stearate and a gastric soluble film coating premix. The production method comprises the steps of fabricating tablets and coatings, and the like. The leflunomide tablet disclosed by the invention is high in dissolution rate, good in stability, good in anti-inflammatory analgesic effect, and small in effect on erythrocyte sedimentation rate, and the total effective rate is 85%. The drug disclosed by the invention has the characteristics of being fewer in medication administration times, stable in plasma concentration, long in lasting time and the like.

Description

field of invention [0001] The invention relates to a pharmaceutical preparation for treating rheumatoid arthritis and a preparation method thereof, which belongs to medicine for orthopedic diseases, in particular to a leflunomide tablet and a preparation method thereof. Background of the invention [0002] Arthritis is a common and chronic disease, in which osteoarthritis and rheumatoid arthritis are the main forms. According to reports, about 18% of the people in our country suffer from some form of arthritis, and the number of cases exceeds 200 million. Arthritis is a serious threat to human health, affecting the life and work of patients, making some patients unable to take care of themselves and lose their ability to work. Some patients have restricted activities, joint swelling, stiffness and pain, and severe joint permanent deformation, which is an important cause of disability in the elderly, so timely treatment is required. [0003] Leflunomide (Leflunomide) is a k...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/42A61K9/20A61K47/38A61P19/02A61P29/00
Inventor 王俊国朱金强邓念万伟
Owner 王俊国
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com